{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:11:25Z","timestamp":1792185085104,"version":"4.4.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"DOI":"10.1007\/s11914-026-00969-y","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:16:37Z","timestamp":1778123797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Osteopetrosis: Pathogenesis, Clinical Management, and Emerging Therapies"],"prefix":"10.1007","volume":"24","author":[{"given":"Simone","family":"Donati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Aurilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Palmini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Falsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Zonefrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ranaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Iantomasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"969_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1172-4-5","volume":"4","author":"Z Stark","year":"2009","unstructured":"Stark Z, Savarirayan R. Osteopetrosis. Orphanet J Rare Dis. 2009;4:5.","journal-title":"Orphanet J Rare Dis"},{"key":"969_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.beem.2018.06.003","volume":"32","author":"E Boudin","year":"2018","unstructured":"Boudin E, Van Hul W. Sclerosing bone dysplasias. Best Pract Res Clin Endocrinol Metab. 2018;32:707\u201323.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"969_CR3","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3390\/genes13111965","volume":"13","author":"P Spinnato","year":"2022","unstructured":"Spinnato P, Pedrini E, Petrera MR, Zarantonello P, Trisolino G, Sangiorgi L, Carpenzano M, Cromb\u00e9 A, Tetta C. Spectrum of Skeletal Imaging Features in Osteopetrosis: Inheritance Pattern and Radiological Associations. Genes (Basel). 2022;13:1965.","journal-title":"Genes (Basel)"},{"key":"969_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3126\/kumj.v20i1.49966","volume":"20","author":"M Khadga","year":"2022","unstructured":"Khadga M, Raihanur Rahman M, Benzamin AZ, Ahamed MD, Akter N, Subha S, Hasan NE, Khan M, Rukunuzzaman LN MD. Malignant Infantile Osteopetrosis with Bone Marrow Involvement. Kathmandu Univ Med J (KUMJ). 2022;20:107\u201310.","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"key":"969_CR5","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1056\/NEJMra040952","volume":"351","author":"J Tolar","year":"2004","unstructured":"Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med. 2004;351:2839\u201349.","journal-title":"N Engl J Med"},{"key":"969_CR6","first-page":"497","volume":"112","author":"P de Baat","year":"2005","unstructured":"de Baat P, Heijboer MP, de Baat C. [Osteopetrosis. Classification, etiology, treatment options and implications for oral health]. Ned Tijdschr Tandheelkd. 2005;112:497\u2013503.","journal-title":"Ned Tijdschr Tandheelkd"},{"key":"969_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00247-024-05899-4","volume":"54","author":"MN McLuckey","year":"2024","unstructured":"McLuckey MN, Imel EA, Forbes-Amrhein MM. Osteopetrosis in the pediatric patient: what the radiologist needs to know. Pediatr Radiol. 2024;54:1105\u201315.","journal-title":"Pediatr Radiol"},{"key":"969_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1056\/NEJM198507183130302","volume":"313","author":"WS Sly","year":"1985","unstructured":"Sly WS, Whyte MP, Sundaram V, Tashian RE, Hewett-Emmett D, Guibaud P, Vainsel M, Baluarte HJ, Gruskin A, Al-Mosawi M. Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med. 1985;313:139\u201345.","journal-title":"N Engl J Med"},{"key":"969_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-008-9196-4","volume":"84","author":"A Villa","year":"2009","unstructured":"Villa A, Guerrini MM, Cassani B, Pangrazio A, Sobacchi C. Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcif Tissue Int. 2009;84:1\u201312.","journal-title":"Calcif Tissue Int"},{"key":"969_CR10","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.biocel.2012.05.014","volume":"44","author":"A Qin","year":"2012","unstructured":"Qin A, Cheng TS, Pavlos NJ, Lin Z, Dai KR, Zheng MH. V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption. Int J Biochem Cell Biol. 2012;44:1422\u201335.","journal-title":"Int J Biochem Cell Biol"},{"key":"969_CR11","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/jbmr.2517","volume":"30","author":"E Palagano","year":"2015","unstructured":"Palagano E, Blair HC, Pangrazio A, et al. Buried in the Middle but Guilty: Intronic Mutations in the TCIRG1 Gene Cause Human Autosomal Recessive Osteopetrosis. J Bone Min Res. 2015;30:1814\u201321.","journal-title":"J Bone Min Res"},{"key":"969_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.4274\/jcrpe.2597","volume":"7","author":"K Demir","year":"2015","unstructured":"Demir K, Nalbanto\u011flu \u00d6, Karaer K, Korkmaz HA, Y\u0131ld\u0131z M, Tun\u00e7 S, \u00d6zkan B. Genetic Diagnosis Using Whole Exome Analysis in Two Cases with Malignant Osteopetrosis of Infancy. J Clin Res Pediatr Endocrinol. 2015;7:356\u20137.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"969_CR13","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/bmt.2016.180","volume":"51","author":"TL Bahr","year":"2016","unstructured":"Bahr TL, Lund T, Sando NM, Orchard PJ, Miller WP. Haploidentical transplantation with post-transplant cyclophosphamide following reduced-intensity conditioning for osteopetrosis: outcomes in three children. Bone Marrow Transpl. 2016;51:1546\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"969_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/jbmr.2929","volume":"32","author":"E Palagano","year":"2017","unstructured":"Palagano E, Susani L, Menale C, Ramenghi U, Berger M, Uva P, Oppo M, Vezzoni P, Villa A, Sobacchi C. Synonymous Mutations Add a Layer of Complexity in the Diagnosis of Human Osteopetrosis. J Bone Min Res. 2017;32:99\u2013105.","journal-title":"J Bone Min Res"},{"key":"969_CR15","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/aps.2017.108","volume":"38","author":"X-Y Zhang","year":"2017","unstructured":"Zhang X-Y, He J-W, Fu W-Z, Wang C, Zhang Z-L. Novel mutations of TCIRG1 cause a malignant and mild phenotype of autosomal recessive osteopetrosis (ARO) in four Chinese families. Acta Pharmacol Sin. 2017;38:1456\u201365.","journal-title":"Acta Pharmacol Sin"},{"key":"969_CR16","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1038\/emboj.2011.137","volume":"30","author":"L Leisle","year":"2011","unstructured":"Leisle L, Ludwig CF, Wagner FA, Jentsch TJ, Stauber T. ClC-7 is a slowly voltage-gated 2Cl(-)\/1H(+)-exchanger and requires Ostm1 for transport activity. EMBO J. 2011;30:2140\u201352.","journal-title":"EMBO J"},{"key":"969_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature04535","volume":"440","author":"PF Lange","year":"2006","unstructured":"Lange PF, Wartosch L, Jentsch TJ, Fuhrmann JC. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature. 2006;440:220\u20133.","journal-title":"Nature"},{"key":"969_CR18","doi-asserted-by":"crossref","unstructured":"Fischer T, De Vries L, Meerloo T, Farquhar MG. Promotion of G\u03b1i3 subunit down-regulation by GIPN, a putative E3 ubiquitin ligase that interacts with RGS-GAIP. Proc Natl Acad Sci. 2003;100:8270\u20138275.","DOI":"10.1073\/pnas.1432965100"},{"key":"969_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.cellsig.2008.01.009","volume":"20","author":"ME Feigin","year":"2008","unstructured":"Feigin ME, Malbon CC. OSTM1 regulates beta-catenin\/Lef1 interaction and is required for Wnt\/beta-catenin signaling. Cell Signal. 2008;20:949\u201357.","journal-title":"Cell Signal"},{"key":"969_CR20","doi-asserted-by":"publisher","first-page":"35868","DOI":"10.1074\/jbc.M114.589614","volume":"289","author":"B Shin","year":"2014","unstructured":"Shin B, Yu J, Park E-S, et al. Secretion of a Truncated Osteopetrosis-associated Transmembrane Protein 1 (OSTM1) Mutant Inhibits Osteoclastogenesis through Down-regulation of the B Lymphocyte-induced Maturation Protein 1 (BLIMP1)-Nuclear Factor of Activated T Cells c1 (NFATc1) Axis. J Biol Chem. 2014;289:35868\u201381.","journal-title":"J Biol Chem"},{"key":"969_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/jmedgenet-2011-100520","volume":"49","author":"M Aker","year":"2012","unstructured":"Aker M, Rouvinski A, Hashavia S, et al. An SNX10 mutation causes malignant osteopetrosis of infancy. J Med Genet. 2012;49:221\u20136.","journal-title":"J Med Genet"},{"key":"969_CR22","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1002\/jcb.26132","volume":"118","author":"C Zhou","year":"2017","unstructured":"Zhou C, Wang Y, Peng J, Li C, Liu P, Shen X. SNX10 Plays a Critical Role in MMP9 Secretion via JNK-p38-ERK Signaling Pathway. J Cell Biochem. 2017;118:4664\u201371.","journal-title":"J Cell Biochem"},{"key":"969_CR23","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1038\/s41598-017-02533-2","volume":"7","author":"E-L Stattin","year":"2017","unstructured":"Stattin E-L, Henning P, Klar J, et al. SNX10 gene mutation leading to osteopetrosis with dysfunctional osteoclasts. Sci Rep. 2017;7:3012.","journal-title":"Sci Rep"},{"key":"969_CR24","doi-asserted-by":"publisher","first-page":"e86330","DOI":"10.1172\/jci.insight.86330","volume":"1","author":"T Fujiwara","year":"2016","unstructured":"Fujiwara T, Ye S, Castro-Gomes T, et al. PLEKHM1\/DEF8\/RAB7 complex regulates lysosome positioning and bone homeostasis. JCI Insight. 2016;1:e86330.","journal-title":"JCI Insight"},{"key":"969_CR25","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1083\/jcb.201607085","volume":"216","author":"R Marwaha","year":"2017","unstructured":"Marwaha R, Arya SB, Jagga D, Kaur H, Tuli A, Sharma M. The Rab7 effector PLEKHM1 binds Arl8b to promote cargo traffic to lysosomes. J Cell Biol. 2017;216:1051\u201370.","journal-title":"J Cell Biol"},{"key":"969_CR26","doi-asserted-by":"publisher","first-page":"e0127537","DOI":"10.1371\/journal.pone.0127537","volume":"10","author":"H Witwicka","year":"2015","unstructured":"Witwicka H, Jia H, Kutikov A, Reyes-Gutierrez P, Li X, Odgren PR. TRAFD1 (FLN29) Interacts with Plekhm1 and Regulates Osteoclast Acidification and Resorption. PLoS ONE. 2015;10:e0127537.","journal-title":"PLoS ONE"},{"key":"969_CR27","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/ng2076","volume":"39","author":"C Sobacchi","year":"2007","unstructured":"Sobacchi C, Frattini A, Guerrini MM, et al. Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat Genet. 2007;39:960\u20132.","journal-title":"Nat Genet"},{"key":"969_CR28","doi-asserted-by":"publisher","first-page":"412768","DOI":"10.1155\/2013\/412768","volume":"2013","author":"N Lo Iacono","year":"2013","unstructured":"Lo Iacono N, Pangrazio A, Abinun M, Bredius R, Zecca M, Blair HC, Vezzoni P, Villa A, Sobacchi C. RANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare disease. Clin Dev Immunol. 2013;2013:412768.","journal-title":"Clin Dev Immunol"},{"key":"969_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ajhg.2008.06.015","volume":"83","author":"MM Guerrini","year":"2008","unstructured":"Guerrini MM, Sobacchi C, Cassani B, et al. Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet. 2008;83:64\u201376.","journal-title":"Am J Hum Genet"},{"key":"969_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/jbmr.559","volume":"27","author":"A Pangrazio","year":"2012","unstructured":"Pangrazio A, Cassani B, Guerrini MM, et al. RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations. J Bone Min Res. 2012;27:342\u201351.","journal-title":"J Bone Min Res"},{"key":"969_CR31","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.3892\/mmr.2015.3152","volume":"11","author":"W Liu","year":"2015","unstructured":"Liu W, Zhang X. Receptor activator of nuclear factor-\u03baB ligand (RANKL)\/RANK\/osteoprotegerin system in bone and other tissues (review). Mol Med Rep. 2015;11:3212\u20138.","journal-title":"Mol Med Rep"},{"key":"969_CR32","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/stem.2574","volume":"35","author":"F Schena","year":"2017","unstructured":"Schena F, Menale C, Caci E, et al. Murine Rankl-\/- Mesenchymal Stromal Cells Display an Osteogenic Differentiation Defect Improved by a RANKL-Expressing Lentiviral Vector. Stem Cells. 2017;35:1365\u201377.","journal-title":"Stem Cells"},{"key":"969_CR33","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1359\/jbmr.070211","volume":"22","author":"W Balemans","year":"2007","unstructured":"Balemans W, Devogelaer J-P, Cleiren E, Piters E, Caussin E, Van Hul W. Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling. J Bone Min Res. 2007;22:708\u201316.","journal-title":"J Bone Min Res"},{"key":"969_CR34","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1359\/jbmr.060810","volume":"21","author":"DL Ellies","year":"2006","unstructured":"Ellies DL, Viviano B, McCarthy J, Rey J-P, Itasaki N, Saunders S, Krumlauf R. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J Bone Min Res. 2006;21:1738\u201349.","journal-title":"J Bone Min Res"},{"key":"969_CR35","doi-asserted-by":"publisher","first-page":"595653","DOI":"10.3389\/fendo.2020.595653","volume":"11","author":"CL Gregson","year":"2020","unstructured":"Gregson CL, Duncan EL. The Genetic Architecture of High Bone Mass. Front Endocrinol (Lausanne). 2020;11:595653.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"969_CR36","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1056\/NEJM200405133502017","volume":"350","author":"MP Whyte","year":"2004","unstructured":"Whyte MP, Reinus WH, Mumm S. High-bone-mass disease and LRP5. N Engl J Med. 2004;350:2096\u20139. author reply 2096\u20132099.","journal-title":"N Engl J Med"},{"key":"969_CR37","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/jbmr.2706","volume":"31","author":"CL Gregson","year":"2016","unstructured":"Gregson CL, Wheeler L, Hardcastle SA, et al. Mutations in Known Monogenic High Bone Mass Loci Only Explain a Small Proportion of High Bone Mass Cases. J Bone Min Res. 2016;31:640\u20139.","journal-title":"J Bone Min Res"},{"key":"969_CR38","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/S0002-9440(10)63712-1","volume":"164","author":"K Henriksen","year":"2004","unstructured":"Henriksen K, Gram J, Schaller S, Dahl BH, Dziegiel MH, Bollerslev J, Karsdal MA. Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II. Am J Pathol. 2004;164:1537\u201345.","journal-title":"Am J Pathol"},{"key":"969_CR39","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0002-9440(10)61221-7","volume":"167","author":"K Henriksen","year":"2005","unstructured":"Henriksen K, Gram J, H\u00f8egh-Andersen P, Jemtland R, Ueland T, Dziegiel MH, Schaller S, Bollerslev J, Karsdal MA. Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo. Am J Pathol. 2005;167:1341\u20138.","journal-title":"Am J Pathol"},{"key":"969_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00223-005-0027-6","volume":"77","author":"W Balemans","year":"2005","unstructured":"Balemans W, Van Wesenbeeck L, Van Hul W. A clinical and molecular overview of the human osteopetroses. Calcif Tissue Int. 2005;77:263\u201374.","journal-title":"Calcif Tissue Int"},{"key":"969_CR41","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1359\/JBMR.040807","volume":"19","author":"KD H\u00e4usler","year":"2004","unstructured":"H\u00e4usler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J Bone Min Res. 2004;19:1873\u201381.","journal-title":"J Bone Min Res"},{"key":"969_CR42","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1359\/JBMR.040816","volume":"19","author":"ML Johnson","year":"2004","unstructured":"Johnson ML, Harnish K, Nusse R, Van Hul W. LRP5 and Wnt signaling: a union made for bone. J Bone Min Res. 2004;19:1749\u201357.","journal-title":"J Bone Min Res"},{"key":"969_CR43","doi-asserted-by":"publisher","first-page":"28611","DOI":"10.1074\/jbc.M113.509364","volume":"288","author":"CF Ludwig","year":"2013","unstructured":"Ludwig CF, Ullrich F, Leisle L, Stauber T, Jentsch TJ. Common gating of both CLC transporter subunits underlies voltage-dependent activation of the 2Cl-\/1H+ exchanger ClC-7\/Ostm1. J Biol Chem. 2013;288:28611\u20139.","journal-title":"J Biol Chem"},{"key":"969_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-008-9196-4","volume":"84","author":"A Villa","year":"2009","unstructured":"Villa A, Guerrini MM, Cassani B, Pangrazio A, Sobacchi C. Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcif Tissue Int. 2009;84:1\u201312.","journal-title":"Calcif Tissue Int"},{"key":"969_CR45","doi-asserted-by":"publisher","first-page":"116541","DOI":"10.1016\/j.bone.2022.116541","volume":"164","author":"C Sobacchi","year":"2022","unstructured":"Sobacchi C, Abinun M. Osteoclast-poor osteopetrosis. Bone. 2022;164:116541.","journal-title":"Bone"},{"key":"969_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11914-018-0415-2","volume":"16","author":"E Palagano","year":"2018","unstructured":"Palagano E, Menale C, Sobacchi C, Villa A. Genetics of Osteopetrosis. Curr Osteoporos Rep. 2018;16:13\u201325.","journal-title":"Curr Osteoporos Rep"},{"key":"969_CR47","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrendo.2013.137","volume":"9","author":"C Sobacchi","year":"2013","unstructured":"Sobacchi C, Schulz A, Coxon FP, Villa A, Helfrich MH. Osteopetrosis: genetics, treatment and new insights into osteoclast function. Nat Rev Endocrinol. 2013;9:522\u201336.","journal-title":"Nat Rev Endocrinol"},{"key":"969_CR48","unstructured":"Jodeh W, Alam I, Econs M. TCIRG1-Related Osteopetrosis. GeneReviews\u00ae. 1993"},{"key":"969_CR49","unstructured":"Sobacchi C, Villa A, Schulz A, Kornak U. CLCN7-Related Osteopetrosis. GeneReviews\u00ae. 1993"},{"key":"969_CR50","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1002\/jbmr.70","volume":"25","author":"J Power","year":"2010","unstructured":"Power J, Poole KES, van Bezooijen R, Doube M, Caballero-Al\u00edas AM, Lowik C, Papapoulos S, Reeve J, Loveridge N. Sclerostin and the regulation of bone formation: Effects in hip osteoarthritis and femoral neck fracture. J Bone Min Res. 2010;25:1867\u201376.","journal-title":"J Bone Min Res"},{"key":"969_CR51","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.joca.2011.04.014","volume":"19","author":"BY Chan","year":"2011","unstructured":"Chan BY, Fuller ES, Russell AK, et al. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage. 2011;19:874\u201385.","journal-title":"Osteoarthritis Cartilage"},{"key":"969_CR52","doi-asserted-by":"publisher","first-page":"100069","DOI":"10.1016\/j.jcjp.2022.100069","volume":"2","author":"ET Sayegh","year":"2022","unstructured":"Sayegh ET, Zgoda M, Leite CBG, Carrano AC, Tambiah J, Lattermann C. Inhibition of Wnt pathway activity as a treatment approach for human osteoarthritis: a systematic review. J Cartil Joint Preservation. 2022;2:100069.","journal-title":"J Cartil Joint Preservation"},{"key":"969_CR53","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3390\/genes13111965","volume":"13","author":"P Spinnato","year":"2022","unstructured":"Spinnato P, Pedrini E, Petrera MR, Zarantonello P, Trisolino G, Sangiorgi L, Carpenzano M, Cromb\u00e9 A, Tetta C. Spectrum of Skeletal Imaging Features in Osteopetrosis: Inheritance Pattern and Radiological Associations. Genes (Basel). 2022;13:1965.","journal-title":"Genes (Basel)"},{"key":"969_CR54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/pbc.20759","volume":"48","author":"SC Kaste","year":"2007","unstructured":"Kaste SC, Kasow KA, Horwitz EM. Quantitative bone mineral density assessment in malignant infantile osteopetrosis. Pediatr Blood Cancer. 2007;48:181\u20135.","journal-title":"Pediatr Blood Cancer"},{"key":"969_CR55","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00256-020-03625-3","volume":"50","author":"LM Ladd","year":"2021","unstructured":"Ladd LM, Imel EA, Niziolek PJ, Liu Z, Warden SJ, Liang Y, Econs MJ. Radiographic imaging, densitometry and disease severity in Autosomal dominant osteopetrosis type 2. Skeletal Radiol. 2021;50:903\u201313.","journal-title":"Skeletal Radiol"},{"key":"969_CR56","doi-asserted-by":"publisher","first-page":"e22471","DOI":"10.1096\/fj.202200678R","volume":"36","author":"I Alam","year":"2022","unstructured":"Alam I, Gerard-O\u2019Riley RL, Acton D, et al. Bone marrow transplantation as a therapy for autosomal dominant osteopetrosis type 2 in mice. FASEB J. 2022;36:e22471.","journal-title":"FASEB J"},{"key":"969_CR57","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/jbmr.2715","volume":"31","author":"M Arruda","year":"2016","unstructured":"Arruda M, Coelho MCA, Moraes AB, de Paula Paranhos-Neto F, Madeira M, Farias MLF, Vieira Neto L. Bone Mineral Density and Microarchitecture in Patients With Autosomal Dominant Osteopetrosis: A Report of Two Cases. J Bone Min Res. 2016;31:657\u201362.","journal-title":"J Bone Min Res"},{"key":"969_CR58","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/0972-3919.147544","volume":"30","author":"C Sit","year":"2015","unstructured":"Sit C, Agrawal K, Fogelman I, Gnanasegaran G. Osteopetrosis: radiological & radionuclide imaging. Indian J Nucl Med. 2015;30:55\u20138.","journal-title":"Indian J Nucl Med"},{"key":"969_CR59","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1210\/jc.2017-01127","volume":"102","author":"CC Wu","year":"2017","unstructured":"Wu CC, Econs MJ, DiMeglio LA, et al. Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group. J Clin Endocrinol Metab. 2017;102:3111\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"969_CR60","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1210\/jc.2017-01127","volume":"102","author":"CC Wu","year":"2017","unstructured":"Wu CC, Econs MJ, DiMeglio LA, et al. Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group. J Clin Endocrinol Metab. 2017;102:3111\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"969_CR61","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/jbmr.2545","volume":"30","author":"I Alam","year":"2015","unstructured":"Alam I, Gray AK, Acton D, Gerard-O\u2019Riley RL, Reilly AM, Econs MJ. Interferon Gamma, but not Calcitriol Improves the Osteopetrotic Phenotypes in ADO2 Mice. J Bone Min Res. 2015;30:2005\u201313.","journal-title":"J Bone Min Res"},{"key":"969_CR62","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJM199506153322402","volume":"332","author":"LL Key","year":"1995","unstructured":"Key LL, Rodriguiz RM, Willi SM, Wright NM, Hatcher HC, Eyre DR, Cure JK, Griffin PP, Ries WL. Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med. 1995;332:1594\u20139.","journal-title":"N Engl J Med"},{"key":"969_CR63","doi-asserted-by":"publisher","first-page":"e10597","DOI":"10.1002\/jbm4.10597","volume":"6","author":"A Nguyen","year":"2022","unstructured":"Nguyen A, Miller WP, Gupta A, Lund TC, Schiferl D, Lam LSK, Arzumanyan Z, Orchard PJ, Polgreen LE. Open-Label Pilot Study of Interferon Gamma-1b in Patients With Non-Infantile Osteopetrosis. JBMR Plus. 2022;6:e10597.","journal-title":"JBMR Plus"},{"key":"969_CR64","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/jbmr.3715","volume":"34","author":"EA Imel","year":"2019","unstructured":"Imel EA, Liu Z, Acton D, Coffman M, Gebregziabher N, Tong Y, Econs MJ. Interferon Gamma-1b Does Not Increase Markers of Bone Resorption in Autosomal Dominant Osteopetrosis. J Bone Min Res. 2019;34:1436\u201345.","journal-title":"J Bone Min Res"},{"key":"969_CR65","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1002\/jbmr.4037","volume":"35","author":"G Shapiro","year":"2020","unstructured":"Shapiro G, Fishleder J, Stepensky P, Simanovsky N, Goldman V, Lamdan R. Skeletal Changes After Hematopoietic Stem Cell Transplantation in Osteopetrosis. J Bone Min Res. 2020;35:1645\u201351.","journal-title":"J Bone Min Res"},{"key":"969_CR66","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1182\/blood-2015-01-625541","volume":"126","author":"PJ Orchard","year":"2015","unstructured":"Orchard PJ, Fasth AL, Le Rademacher J, et al. Hematopoietic stem cell transplantation for infantile osteopetrosis. Blood. 2015;126:270\u20136.","journal-title":"Blood"},{"key":"969_CR67","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2165\/00002018-200730100-00005","volume":"30","author":"L Fardet","year":"2007","unstructured":"Fardet L, Kassar A, Cabane J, Flahault A. Corticosteroid-induced adverse events in adults: frequency, screening and prevention. Drug Saf. 2007;30:861\u201381.","journal-title":"Drug Saf"},{"key":"969_CR68","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S8756-3282(99)00278-1","volume":"26","author":"JC Scimeca","year":"2000","unstructured":"Scimeca JC, Franchi A, Trojani C, Parrinello H, Grosgeorge J, Robert C, Jaillon O, Poirier C, Gaudray P, Carle GF. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc\/oc) mutants. Bone. 2000;26:207\u201313.","journal-title":"Bone"},{"key":"969_CR69","doi-asserted-by":"publisher","first-page":"5178","DOI":"10.1182\/blood-2006-12-061382","volume":"109","author":"MK Johansson","year":"2007","unstructured":"Johansson MK, de Vries TJ, Schoenmaker T, Ehinger M, Brun ACM, Fasth A, Karlsson S, Everts V, Richter J. Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc\/oc mice. Blood. 2007;109:5178\u201385.","journal-title":"Blood"},{"key":"969_CR70","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.ymthe.2017.03.018","volume":"25","author":"AJ Thrasher","year":"2017","unstructured":"Thrasher AJ, Williams DA. Evolving Gene Therapy in Primary Immunodeficiency. Mol Ther. 2017;25:1132\u201341.","journal-title":"Mol Ther"},{"key":"969_CR71","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1089\/hum.2019.047","volume":"30","author":"H L\u00f6fvall","year":"2019","unstructured":"L\u00f6fvall H, Rothe M, Schambach A, Henriksen K, Richter J, Moscatelli I. Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in oc\/oc Mice. Hum Gene Ther. 2019;30:1395\u2013404.","journal-title":"Hum Gene Ther"},{"key":"969_CR72","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3324\/haematol.2019.238261","volume":"106","author":"V Capo","year":"2020","unstructured":"Capo V, Penna S, Merelli I, et al. Expanded circulating hematopoietic stem\/ progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis. Haematologica. 2020;106:74\u201386.","journal-title":"Haematologica"},{"key":"969_CR73","doi-asserted-by":"publisher","first-page":"412768","DOI":"10.1155\/2013\/412768","volume":"2013","author":"N Lo Iacono","year":"2013","unstructured":"Lo Iacono N, Pangrazio A, Abinun M, Bredius R, Zecca M, Blair HC, Vezzoni P, Villa A, Sobacchi C. RANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare disease. Clin Dev Immunol. 2013;2013:412768.","journal-title":"Clin Dev Immunol"},{"key":"969_CR74","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.biomaterials.2014.12.033","volume":"46","author":"A Cappariello","year":"2015","unstructured":"Cappariello A, Paone R, Maurizi A, Capulli M, Rucci N, Muraca M, Teti A. Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-\u03baB Ligand (RANKL) active domain into the circulation. Biomaterials. 2015;46:58\u201369.","journal-title":"Biomaterials"},{"key":"969_CR75","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/sctm.18-0085","volume":"8","author":"C Menale","year":"2019","unstructured":"Menale C, Campodoni E, Palagano E, et al. Mesenchymal Stromal Cell-Seeded Biomimetic Scaffolds as a Factory of Soluble RANKL in Rankl-Deficient Osteopetrosis. Stem Cells Transl Med. 2019;8:22\u201334.","journal-title":"Stem Cells Transl Med"},{"key":"969_CR76","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","volume":"9","author":"J Cerneckis","year":"2024","unstructured":"Cerneckis J, Cai H, Shi Y. Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications. Sig Transduct Target Ther. 2024;9:112.","journal-title":"Sig Transduct Target Ther"},{"key":"969_CR77","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.stemcr.2015.08.005","volume":"5","author":"T Neri","year":"2015","unstructured":"Neri T, Muggeo S, Paulis M, et al. Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts. Stem Cell Rep. 2015;5:558\u201368.","journal-title":"Stem Cell Rep"},{"key":"969_CR78","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.2106\/JBJS.19.00558","volume":"101","author":"W Chen","year":"2019","unstructured":"Chen W, Twaroski K, Eide C, Riddle MJ, Orchard PJ, Tolar J. TCIRG1 Transgenic Rescue of Osteoclast Function Using Induced Pluripotent Stem Cells Derived from Patients with Infantile Malignant Autosomal Recessive Osteopetrosis. J Bone Joint Surg Am. 2019;101:1939\u201347.","journal-title":"J Bone Joint Surg Am"},{"key":"969_CR79","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13287-020-01701-y","volume":"11","author":"X Xian","year":"2020","unstructured":"Xian X, Moraghebi R, L\u00f6fvall H, Fasth A, Henriksen K, Richter J, Woods N-B, Moscatelli I. Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cells. Stem Cell Res Ther. 2020;11:179.","journal-title":"Stem Cell Res Ther"},{"key":"969_CR80","doi-asserted-by":"publisher","first-page":"131","DOI":"10.31083\/j.fbl2806131","volume":"28","author":"D Li","year":"2023","unstructured":"Li D, Ou M, Zhang W, et al. CRISPR\/Cas9-Mediated Gene Correction in Osteopetrosis Patient-Derived iPSCs. Front Biosci (Landmark Ed). 2023;28:131.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"969_CR81","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.scr.2017.07.024","volume":"24","author":"M Xu","year":"2017","unstructured":"Xu M, Stattin E-L, Murphy M, Barry F. Generation of induced pluripotent stem cells (ARO-iPSC1-11) from a patient with autosomal recessive osteopetrosis harboring the c.212\u2009+\u20091G\u2009>\u2009T mutation in SNX10 gene. Stem Cell Res. 2017;24:51\u20134.","journal-title":"Stem Cell Res"},{"key":"969_CR82","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1017\/S0016672318000034","volume":"100","author":"T Huang","year":"2018","unstructured":"Huang T, Peng X, Li Z, Zhou Q, Huang S, Wang Y, Li J, Song Y. Epigenetics and bone diseases. Genet Res (Camb). 2018;100:e6.","journal-title":"Genet Res (Camb)"},{"key":"969_CR83","doi-asserted-by":"publisher","first-page":"7592","DOI":"10.3390\/ijms21207592","volume":"21","author":"S Donati","year":"2020","unstructured":"Donati S, Ciuffi S, Marini F, Palmini G, Miglietta F, Aurilia C, Brandi ML. Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome. Int J Mol Sci. 2020;21:7592.","journal-title":"Int J Mol Sci"},{"key":"969_CR84","doi-asserted-by":"publisher","first-page":"E1329","DOI":"10.3390\/ijms17081329","volume":"17","author":"F Marini","year":"2016","unstructured":"Marini F, Cianferotti L, Brandi ML. Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices? Int J Mol Sci. 2016;17:E1329.","journal-title":"Int J Mol Sci"},{"key":"969_CR85","doi-asserted-by":"publisher","first-page":"241","DOI":"10.21037\/atm.2018.06.10","volume":"6","author":"MA Diamantopoulos","year":"2018","unstructured":"Diamantopoulos MA, Tsiakanikas P, Scorilas A. Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer. Ann Transl Med. 2018;6:241.","journal-title":"Ann Transl Med"},{"key":"969_CR86","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/ejhg.2013.221","volume":"22","author":"M Ou","year":"2014","unstructured":"Ou M, Zhang X, Dai Y, Gao J, Zhu M, Yang X, Li Y, Yang T, Ding M. Identification of potential microRNA\u2013target pairs associated with osteopetrosis by deep sequencing, iTRAQ proteomics and bioinformatics. Eur J Hum Genet. 2014;22:625\u201332.","journal-title":"Eur J Hum Genet"},{"key":"969_CR87","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1074\/jbc.M805777200","volume":"284","author":"T Sugatani","year":"2009","unstructured":"Sugatani T, Hruska KA. Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem. 2009;284:4667\u201378.","journal-title":"J Biol Chem"},{"key":"969_CR88","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/jcp.27031","volume":"234","author":"C Liu","year":"2019","unstructured":"Liu C, Cao Z, Bai Y, et al. LncRNA AK077216 promotes RANKL-induced osteoclastogenesis and bone resorption via NFATc1 by inhibition of NIP45. J Cell Physiol. 2019;234:1606\u201317.","journal-title":"J Cell Physiol"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-026-00969-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-026-00969-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-026-00969-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:02:27Z","timestamp":1778140947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-026-00969-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["969"],"URL":"https:\/\/doi.org\/10.1007\/s11914-026-00969-y","relation":{},"ISSN":["1544-2241"],"issn-type":[{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}